Rezolute Inc (RZLT)
4.98
+0.10
(+2.05%)
USD |
NASDAQ |
Sep 27, 16:00
4.985
0.00 (0.00%)
After-Hours: 20:00
Rezolute Cash from Financing (Quarterly): 63.32M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 63.32M |
| March 31, 2024 | -0.003M |
| December 31, 2023 | -0.293M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 11.57M |
| June 30, 2022 | 94.10M |
| March 31, 2022 | -0.019M |
| December 31, 2021 | 52.31M |
| September 30, 2021 | 2.586M |
| June 30, 2021 | 14.29M |
| March 31, 2021 | -0.214M |
| December 31, 2020 | 37.46M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.021M |
| September 30, 2019 | 22.57M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 23.50M |
| December 31, 2018 | 1.50M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 3.90M |
| Date | Value |
|---|---|
| March 31, 2018 | 1.20M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 4.44M |
| June 30, 2017 | 3.776M |
| March 31, 2017 | 4.50M |
| December 31, 2016 | 3.322M |
| September 30, 2016 | 2.333M |
| June 30, 2016 | 5.785M |
| March 31, 2016 | 3.093M |
| December 31, 2015 | 1.871M |
| September 30, 2015 | -0.0231M |
| June 30, 2015 | 1.250M |
| March 31, 2015 | 2.601M |
| December 31, 2014 | 6.185M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 3.211M |
| March 31, 2014 | 5.208M |
| December 31, 2013 | 1.513M |
| September 30, 2013 | 0.00 |
| June 30, 2013 | -0.1575M |
| March 31, 2013 | 0.27M |
| December 31, 2012 | 0.63M |
| September 30, 2012 | 0.675M |
| June 30, 2012 | -1.154M |
| March 31, 2012 | 1.164M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.293M
Minimum
Dec 2023
94.10M
Maximum
Jun 2022
14.88M
Average
--
Median
Mar 2020
Cash from Financing (Quarterly) Benchmarks
| Actinium Pharmaceuticals Inc | 9.954M |
| Moderna Inc | 34.00M |
| NovaBay Pharmaceuticals Inc | -0.492M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 12.99M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.52M |
| Cash from Investing (Quarterly) | 19.66M |
| Free Cash Flow | -57.37M |
| Free Cash Flow Per Share (Quarterly) | -0.3547 |
| Free Cash Flow Yield | -22.38% |